Coverage includes:
- Coronary Artery Disease
- Diabetes
- Biomarkers
- Valvular Heart Disease
- Congestive Heart Failure
- Cardiomyopathies
- Dyslipidemia
- Atrial Fibrillation
- Supraventricular Tachycardia
- Spontaneous Coronary Artery Dissection
- Ventricular Arrhythmias
- Advances in Electrical Devices
- Exercise and Heart Disease
- Thoracic Aortic Disease
- Adult Congenital Heart Disease
- Heart Disease in Pregnancy
- Cardio-oncology
- Peripheral Arterial Disease
- Pulmonary Embolism
- Cardiac Critical Care
- Cardiomyopathy with Thick Ventricular Walls
The 2022 program offers you the opportunity to learn:
Important medical and procedural advances for the management of common clinical problems such as coronary artery disease and heart failure (including heart failure with preserved ejection fraction)
The latest transcatheter options
Best practices to treat patients with severe valvular disease
Important techniques for managing heart disease in pregnancy
The new paradigms for care of specialized populations, such as adults with congenital heart disease, cardiac patients with cancer, and athletic individuals
The latest concepts of diagnosis, decision-making, pharmacology, and therapy in the areas of ischemic heart disease, cardiac arrhythmias, and congestive heart failure
The faculty is assembled from the best clinician-educators at Harvard Medical School and Massachusetts General Hospital and is designed to deliver the highest quality educational experience:
Teaching practical, effective clinical reasoning and approaches that enable you to practice state-of-the-art clinical cardiology
Allowing ample time for participants to interact with faculty and to pose and get answers to your specific questions
Providing the latest information in an engaging manner and clinically usable context so that you have knowledge you can “take home” and immediately apply to patient care
Schedule :
Wednesday, October 12, 2022
Wednesday Morning Session
- Moderator: Adolph M. Hutter, Jr., MD
- IntroductionAdolph M. Hutter, Jr., MD
- The New Role of the Cardiologist in Diabetes ManagementJames L. Januzzi, MD
- Q&A SessionJames L. Januzzi, MD
- Pulmonary Embolism Response Team (PERT)Ido Weinberg, MD
- Q&A SessionIdo Weinberg, MD
- Catheter Techniques to Define Mechanisms of IschemiaAkl Fahed, MD
- Q&A SessionAkl Fahed, MD
- Updates to Evaluate and Treat Adult Congenital Heart DiseaseChristopher Learn, MD
- Q&A SessionChristopher Learn, MD
- Mitral Regurgitation: Timing of Intervention and Choosing between Surgery and Percutaneous TherapyEric M. Isselbacher, MD
- Q&A SessionEric M. Isselbacher, MD
Wednesday Afternoon Session
Moderator: Rory B. Weiner, MD
Advances in Medical Treatment of Systolic Heart FailureDaniel Zlotoff, MD
Q&A SessionDaniel Zlotoff, MD
Advanced Heart Failure: Acute and Chronic TherapyErin E. Coglianese, MD
Q&A SessionErin E. Coglianese, MD
Heart Failure with Preserved Ejection Fraction (HFpEF)Gregory D. Lewis, MD
Q&A SessionGregory D. Lewis, MD
What’s New in Cardiac MarkersJames L. Januzzi, MD
Q&A SessionJames L. Januzzi, MD
Thursday, October 13, 2022
Thursday Morning Session
Moderator: Rory B. Weiner, MD
IntroductionRory B. Weiner, MD
Incorporating Advances in Electrical Therapy in Heart Failure for Improved Patient OutcomesJagmeet P. Singh, MD, PhD
Q&A SessionJagmeet P. Singh, MD, PhD
Atrial Fibrillation: Recent Advances in Pharmacologic and Nonpharmacologic TherapyMoussa C. Mansour, MD
Q&A SessionMoussa C. Mansour, MD
The Newest Approaches to Stroke Prevention in Atrial FibrillationE. Kevin Heist, MD, PhD
Q&A SessionE. Kevin Heist, MD, PhD
New Technologies in the EP Lab: Device Extractions, Leadless Pacemakers and Remote MonitoringTheofanie Mela, MD
Q&A SessionTheofanie Mela, MD
Dual Antiplatelet Therapy in Cardiovascular DiseaseMichelle L. O’Donoghue, MD
Q&A SessionMichelle L. O’Donoghue, MD
Lunch Break*
Thursday Afternoon Session
- Moderator: Doreen DeFaria Yeh, MD
- Aortic Stenosis: Timing of Intervention and Choosing between Surgery and Percutaneous TherapyNilay K. Patel, MD
- Q&A SessionNilay K. Patel, MD
- Thoracic Aortic Disease: Optimal Imaging and ManagementEric M. Isselbacher, MD
- Q&A SessionEric M. Isselbacher, MD
- Acute Coronary Syndromes – STEMI and NSTEMI: The New Data and Clinical ImplicationsMarc S. Sabatine, MD, MPH
- Q&A SessionMarc S. Sabatine, MD, MPH
- Cardiomyopathies with Thick WallsAlbree Tower-Rader, MD
- Q&A SessionAlbree Tower-Rader, MD
Friday, October 14, 2022
Friday Morning Session
- Moderator: Adolph M. Hutter, Jr., MD
- IntroductionAdolph M. Hutter, Jr., MD
Cardiovascular Care of Aging Athletes: Progress and Future ChallengesMeagan Murphy Wasfy, MD
Q&A SessionMeagan Murphy Wasfy, MD
How Exercise Protects the HeartJ. Sawalla Guseh, MD
Q&A SessionJ. Sawalla Guseh, MD - State-of-the-Art Approaches to Cardio-Oncology 2022Tomas G. Neilan, MD, MPH, MRCPI
Q&A SessionTomas G. Neilan, MD, MPH, MRCPI
Update in Cardiovascular Disease and PregnancyNandita S. Scott, MD
Q&A SessionNandita S. Scott, MD
Coronary Disease: Medicate/Dilate/OperateRahul Sakhuja, MD, MPP
Q&A SessionRahul Sakhuja, MD, MPP
Friday Afternoon Session
Moderator: Rory B. Weiner, MD
Spontaneous Coronary Artery Dissection (SCAD)Malissa Wood, MD
Q&A SessionMalissa Wood, MD
Complex Coronary Artery Disease in the Cath LabFarouc A. Jaffer, MD, PhD
Q&A SessionFarouc A. Jaffer, MD, PhD
Dyslipidemia: Latest ConceptsPradeep Natarajan, MD
Q&A SessionPradeep Natarajan, MD
Cardiac Critical CareDavid M. Dudzinski, MD
Q&A SessionDavid M. Dudzinski, MD
Closing RemarksAdolph M. Hutter, Jr., MD
